US 10611827
Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins
granted A61KA61K2039/505A61K39/42
Quick answer
US patent 10611827 (Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins) held by INTEGRATED BIOTHERAPEUTICS, INC. expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INTEGRATED BIOTHERAPEUTICS, INC.
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K39/42